2nd Translational Research Conference
Chronic Lymphocytic Leukaemia
Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek

2nd Translational Research Conference
Chronic Lymphocytic Leukaemia
Information
ABOUT THE CONFERENCE:
The 2nd ESH TRANSLATIONAL RESEARCH CONFERENCE ON CHRONIC LYMPHOCYTIC LEUKAEMIA can now be held in person to achieve again scientific interactions that are the primary goal of our gathering. The Conference is proposing a programme of leading-edge basic and clinical science where a panel of global experts in the field will provide numerous opportunities for formal and informal interactions to discuss the present and the future of CLL research. It is open to an international audience of biologists and clinicians, particularly welcoming those in-training.
This translational research conference will explore the most recent advances in the understanding of the pathogenesis and clinical management of the disease. Open and spirited discussion on the most up-to-date information in the field is expected to understand how the many new biologic insights apply to the future of CLL.
SCIENTIFIC TOPICS:
• Spectrum of CLL disease: MBL to Richter’s transformation
• New insights in “old” biomarkers
• Taking driver gene mutations to the next level
• Beyond BcR: other microenvironmental stimuli
• Time-limited therapy
• Covalent BTK inhibitors
• BTK and Bcl2 inhibitor resistance
• Next generation therapies
• The future: other targets
Programme
Read the final programme!



